Press release
4 March 2009
BioGaia product launched as pharmaceutical in India
BioGaia has signed an agreement with Tablets India Ltd. for the production and
sale of products based on BioGaia's probiotics on the Indian market. The launch
is planned in the first half of 2009.
The first product to be launched on the Indian market is a capsule under the
brand name Apylori Probiotic Capsules. The product is manufactured by Tablets
India and registered as a pharmaceutical which will be prescribed by physicians
and distributed through pharmacies.
”The agreement with Tablets India Ltd. is of strategic importance for BioGaia.
We know that the Indian market is very large and fragmented and it is thus of
great importance for BioGaia to enter an agreement with a well-established
partner with long experience. We eagerly await the launch of the first
product.” says Peter Rothschild, President BioGaia.
Tablets India Ltd. which was founded in 1938, has a series of collaborations
with large Japanese and European pharmaceutical companies. The company has more
than 1000 employees and distribution over the whole of India. Production takes
place in modern GMP certified facilities.
BioGaia sells products in some 40 countries.
Latest press releases from BioGaia:
2009-03-12 BioGaia Probiotic chewable tablets effective in decreasing diarrhoea
caused by antibiotics
2009-02-12 Year-end report 2008
2009-01-12 CapAble signs agreement in Mexico
For additional information contact: Peter Rothschild, Managing Director,
telephone: +46 8 - 555 293 00,
Jan Annwall deputy Managing Director telephone: +46 8 - 555 293 00
BioGaia is a biotechnology company that develops, markets and sells probiotic
products with documented health benefits. The products are primarily based on
the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic,
health-enhancing effects. The class B share of the Parent Company BioGaia AB is
quoted on the Small Cap list of the Nordic Stock Exchange in Stockholm.
www.biogaia.com
